Skip to main content
SpringerLink
Log in

In Vitro Predictive Sensitivity Testing in the Therapeutic Assessment of Breast Cancer

  • Chapter
High-Risk Breast Cancer

Abstract

The choice of endocrine therapy and chemotherapy used in the treatment of breast cancer is largely empirically derived, based on data obtained from clinical trials [32]. However, patients with the same tumor pathology may not respond to the same cytotoxic drugs. Steroid hormone receptors, used to predict hormone responsiveness of breast tumors, greatly improve the probability of response, but does not ensure that a patient will benefit from endocrine manipulations. Inappropriate treatments result in valuable time lost for alternative therapy and unnecessary suffering from side effects of antineoplastic agents. A major aspect of breast cancer biology responsible for therapeutic failures is tumor heterogeneity; tumors contain varying numbers of hormone- and drug-responsive and hormone- and drug-resistant cells [47].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alberts DS, Salmon SE, Chen HSG, Moon TE, Young L, Surwit EA (1981) Pharmacologic studies of anticancer drugs with the human tumor stem cell assay. Cancer Chemother Pharmacol 6:253–264

    PubMed  CAS  Google Scholar 

  2. Albrecht M, Simon WE, Hölzel F (1985) Individual chemosensitivity of in vitro proliferating mammary and ovarian carcinoma cells in comparison to clinical results of chemotherapy. J Cancer Res Clin Oncol 109: 210–216

    PubMed  CAS  Google Scholar 

  3. Alley MC, Powis G, Appel PL, Kooistra KL, Lieber MM (1984) Activation and inactivation of cancer chemotherapeutic agents by rat hepatocytes cocultured with human tumor cell lines. Cancer Res 44: 549–556

    PubMed  CAS  Google Scholar 

  4. Barnes D, Sato G (1980) Methods for growth of cultured cells in serum-free medium. Anal Biochem 102: 255–270

    PubMed  CAS  Google Scholar 

  5. Benz C, Cadman E, Gwin J, Terrence W, Amara J, Eisenfeld A, Dannies P (1983) Tamoxifen and 5-fluorouracil in breast cancer: cytotoxic synergism in vitro. Cancer Res 43: 5298–5303

    PubMed  CAS  Google Scholar 

  6. Berry RJ, Laing AH, Wills J (1975) Fresh explant culture of human tumours in vitro and the assessment of sensitivity to cytotoxic chemotherapy. Br J Cancer 31:218–227

    PubMed  CAS  Google Scholar 

  7. Bertelsen CA, Sondak VK, Mann BD, Korn EL, Kern DH (1984) Chemosensitivity testing of human solid tumors: a review of 1582 assays with 258 clinical correlations. Cancer 53: 1240–1245

    PubMed  CAS  Google Scholar 

  8. Bickis IJ, Henderson IWD, Quaster JH (1966) Biochemical studies of human tumors. II. In vitro estimation of individual tumor sensitivity to anticancer agents Cancer 19· 103–113

    PubMed  CAS  Google Scholar 

  9. Brereton HD, Bryant TL, Young RC (1975) Inhibition and recovery of DNA synthesis in host tissues and sensitive and resistant B16 melanoma after l–2(2-chloroethyl)-3- (trans-4-methylcyclohexyl)-1 -nitrosourea, a predictor of therapeutic efficacy. Cancer Res 35: 2420–2425

    PubMed  CAS  Google Scholar 

  10. Carlsson J, Yuhas JM (1984) Liquid-overlay culture of cellular spheroids. In: Acker H, Carlsson J, Durand R, Sutherland R (eds) Spheroids in cancer research. Springer, Berlin Heidelberg New York, pp 1–23 (Recent results in cancer research, vol. 95)

    Google Scholar 

  11. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936–942

    PubMed  CAS  Google Scholar 

  12. Cillo C, Odartchenko N (1984) Cloning of human tumor cells in methylcellulose- containing medium. Hofmann V, Berens ME, Martz G (eds) Predictive drug testing on human tumor cells. Springer, Berlin Heidelbrg New York, pp 56–64 (Recent results in cancer research, vol. 94)

    Google Scholar 

  13. Clarke R, Van den Berg HW, Kennedy DG, Murphy RF (1985) Oestrogen receptor status and the response of human breast cancer cell lines to a combination of methotrexate and 17-β-oestradiol. Br J Cancer 51: 365–369

    PubMed  CAS  Google Scholar 

  14. Conte PF, Fraschini G, Alama A, Nicolin A, Corsaro E, Conavese G, Rosso R, Drewinko B (1985) Chemotherapy following estrogen-induced expansion of the growth fraction of human breast cancer. Cancer Res 45: 5926–5930

    PubMed  CAS  Google Scholar 

  15. Courtenay VD, Mills J (1978) In vitro colony assay for human tumours grown in immunesuppressed mice and treated in vivo with cytotoxic agents. Br J Cancer 37: 261–268

    PubMed  CAS  Google Scholar 

  16. Daidone MG, Silvestrini R, Sanfilippo O, Zaffaroni N, Varini M, De Lena M (1985) Reliability of an in vitro short-term assay to predict the drug sensitivity of human breast cancer. Cancer 56: 450–456

    PubMed  CAS  Google Scholar 

  17. Darling JL, Thomas DGT (1983) Results obtained using assays of intermediate duration and clinical correlations. In: Dendy PP, Hill BT (eds) Human tumour drug sensitivity testing in vitro. Academic, London, pp 269–280

    Google Scholar 

  18. Das NK, Hosick HL, Nandi S (1974) Influences of seeding density on multicellular organization and nuclear events in cultures of normal and neoplastic mouse mammary epithelium. J N C I 52: 849–861

    CAS  Google Scholar 

  19. Dedrick RL, Myers CE, Bungay PM, De Vita VT Jr (1978) Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer Cancer Treat Rep 62: 1–11

    PubMed  CAS  Google Scholar 

  20. Dendy PP, Bozman G, Wheeler TK (1970) In vitro screening test for human malignant tumours before chemotherapy. Lancet ii: 68

    Google Scholar 

  21. Dendy PP, Hill BT (eds) (1983) Human tumour drug sensitivity testing in vitro. Academic, London

    Google Scholar 

  22. Di Paolo JA, Dowd JE (1961) Evaluation of inhibition of human tumour tissue by cancer chemotherapeutic drugs with an in vitro test. J N C I 27: 807–815

    Google Scholar 

  23. Dittrich C, Jakesz R, Wrba F, Havelec L, Haas O, Spona J, Holzner H, Kolb R, Moser K (1985) The human tumour cloning assay in the management of breast cancer patients. Br J Cancer 52: 197–203

    PubMed  CAS  Google Scholar 

  24. Drewinko B, Patchen M, Yang L-Y, Barlogie B (1981) Differential killing efficacy of twenty antitumor drugs on proliferating and nonproliferating human tumor cells Cancer Res 41: 2328–2333

    PubMed  CAS  Google Scholar 

  25. Emerman JT, Bartley JC, Bissel MJ (1981) Glucose metabolite patterns as markers of functional differentiation in freshly isolated and cultured mouse mammary epithelial cells. Exp Cell Res 134: 241–250

    PubMed  CAS  Google Scholar 

  26. Emerman JT, Enami J, Pitelka DR, Nandi S (1977) Hormonal effects on intracellular and secreted casein in cultures of mouse mammary epithelial cells on floating collagen membranes. Proc Natl Acad Sci USA 74: 4466–4470

    PubMed  CAS  Google Scholar 

  27. Emerman JT, Fiedler EE, Tolcher AW, Rebbeck PM (1987) Effects of defined medium, fetal bovine serum, and human serum on growth and chemosensitivities of human breast cancer cells in primary culture: inference for in vitro assays. In Vitro Cell Dev Biol 23: 134–140

    PubMed  CAS  Google Scholar 

  28. Emerman JT, Pitelka DR (1977) Maintenance and induction of morphological differentiation in dissociated mammary epithelium on floating collagen membranes. In Vitro 13: 316–328

    PubMed  CAS  Google Scholar 

  29. Emerman JT, Siemiatkowski J (1984) Effects of endocrine regulation of growth of a mouse mammary tumor on its sensitivity to chemotherapy. Cancer Res 44: 1327–1332

    PubMed  CAS  Google Scholar 

  30. Emerman JT, Worth AJ (1985) Phenotypic stability of mouse mammary tumor cells cultured on collagen gels. In Vitro Cell Dev Biol 21: 49–56

    PubMed  CAS  Google Scholar 

  31. Fan D, Schneider C, Fan S, Blank H, Gillen L, Morgan LR (1984) Effects of estrogen, tamoxifen and progesterone on a human breast cancer line in the soft-agar assay. In: Salmon SE, Trent JM (eds) Human tumor cloning. Grune and Stratton, Orlando, pp 477–486

    Google Scholar 

  32. Forrest APM (1986) Advances in management of carcinoma of breast. Surg Gynecol Obstet 163: 89–100

    PubMed  CAS  Google Scholar 

  33. Freshney RI, Dendy PP (1983) Culture methods for assays of intermediate duration. In: Dendy PP, Hill BT (eds) Human tumour drug sensitivity testing in vitro. Academic, London, pp 69–89

    Google Scholar 

  34. Freshney RI, Paul J, Kane IM (1975) Assay of anticancer drugs in tissue culture: conditions affecting their ability to incorporate 3H-leucine after drug treatment. Br J Cancer 31: 89–99

    PubMed  CAS  Google Scholar 

  35. Friedman HM, Glaubiger DL (1982) Assessment of in vitro drug sensitivity of human tumor cells using [3H] thymidine incorporation in a modified human tumor stem cell assay. Cancer Res 42: 4683–4689

    PubMed  CAS  Google Scholar 

  36. Gaffney EV, Pigott D (1978) Hydrocortisone stimulation of human mammary epithelial cells. In Vitro 14: 621–624

    PubMed  CAS  Google Scholar 

  37. Goldenberg GJ, Froese EK (1982) Drug and hormone sensitivity of estrogen receptor- positive and negative human breast cancer cells in vitro. Cancer Res 42: 5147–5151

    PubMed  CAS  Google Scholar 

  38. Goldenberg GJ, Froese EK (1985) Antagonism of the cytocidal activity and uptake of melphalan by tamoxifen in human breast cancer cells in vitro. Biochem Pharmacol 34: 763–770

    PubMed  CAS  Google Scholar 

  39. Group for Sensitivity Testing of Human Tumours (KSST) (1981) In vitro short-term test to determine the resistance of human tumours to chemotherapy. Cancer 48: 2127–2135

    Google Scholar 

  40. Gupta V, Costanzi JJ (1987) Role of hypoxia in anticancer drug-induced cytotoxicity for Ehrlich ascites cells. Cancer Res 47: 2407–2412

    PubMed  CAS  Google Scholar 

  41. Haeuptle M, Suard YLM, Bogenmann E (1983) Effect of cell shape change on the function and differentiation of rabbit mammary cells in culture. J Cell Biol 96: 1425–1434

    PubMed  CAS  Google Scholar 

  42. Haji-karim M, Carlsson J (1978) Proliferation and viability in cellular spheroids of human origin. Cancer Res 38: 1457–1464

    PubMed  CAS  Google Scholar 

  43. Hamburger AW, Salmon SE (1977) Primary bioassay of human tumor stem cells. Science 197: 461–463

    PubMed  CAS  Google Scholar 

  44. Hammond SL, Ham RG, Stampfer MR (1984) Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract. Proc Natl Acad Sci USA 81: 5435–5439

    PubMed  CAS  Google Scholar 

  45. Hanson JA, Bean EA, Coombs AM, Moore JL (1985) A comparison of two in vitro assays of cell response following in vitro drug and radiation exposures of human tumour xenograft cells. Br J Cancer 52: 637–640

    PubMed  CAS  Google Scholar 

  46. Haslam SZ (1986) Mammary fibroblast influence on normal mouse mammary epithelial cell responses to estrogen in vitro. Cancer Res 46: 310–316

    PubMed  CAS  Google Scholar 

  47. Heppner GH, Miller B, Cooper DN, Miller FR (1981) Growth interactions between mammary tumor cells. In: Brenner NJ, McGrath CM (eds) Cell biology of breast cancer. Academic, New York, pp 161–172

    Google Scholar 

  48. Hill BT, Whelan RDH, Rupniak HT, Dennis LY, Rosholt MA (1981) A comparative assessment of the in vitro effects of drugs on cells by means of colony assays or flow microfluorimetry. Cancer Chemother Pharmacol 7: 21–26

    PubMed  CAS  Google Scholar 

  49. Holmes HL, Little JM (1974) Tissue-culture microtest for predicting response of human cancer to chemotherapy. Lancet ii: 985–987

    Google Scholar 

  50. Hölzel F, Albrecht M, Simon WE, Hänsel M, Metz R, Schweizer J, Dietel M (1985) Effectiveness of antineoplastic drugs on the proliferation of human mammary and ovarian carcinoma cells in monolayer culture. J Cancer Res Clin Oncol 109: 217–226

    PubMed  Google Scholar 

  51. Houghton PJ, Taylor DN (1977) Fractional incorporation of [3H] thymidine and DNA specific activity as assays of inhibition of tumour growth. Br J Cancer 35: 68–77

    PubMed  CAS  Google Scholar 

  52. Hug V, Haynes M, Rashid R, Spitzer G, Blumenschen G, Hortobagyi G (1984) Improved culture conditons for clonogenic growth of primary human breast tumours. Br J Cancer 50: 207–213

    PubMed  CAS  Google Scholar 

  53. Hug V, Hortobagyi G, Drewinko B, Finders M (1985) Tamoxifen-citrate counter-acts the antitumor effects of cytotoxic drugs in vitro. J Clin Oncol 3: 1672–1677

    PubMed  CAS  Google Scholar 

  54. Hug V, Johnston D, Finders M, Hortobagyi G (1986) Use of growth-stimulating hormones to improve the in vitro therapeutic index of doxorubicin for human breast tumors. Cancer Res 46: 147–152

    PubMed  CAS  Google Scholar 

  55. Hug V, Thames H, Hortobagyi G, Finders M (1986) Chemosensitivities of human clonogenic breast tumour cells. Eur J Cancer Clin Oncol 22: 971–981

    PubMed  CAS  Google Scholar 

  56. Ikeda T, Liu Q, Danielpour D, Officer JB, Iio M, Leland FE, Sirbasku DA (1982) Identification of estrogen-inducible growth factors (estromedins) for rat and human mammary tumor cells in culture. In Vitro 18: 961–979

    PubMed  CAS  Google Scholar 

  57. Jones CA, Tsukamoto T, O’Brien PC, Uhl CB, Alley MC (1985) Soft agarose culture human tumour colony forming assay for drug sensitivity testing: [3H]-thymidine incorporation vs colony counting. Br J Cancer 52: 303–310

    PubMed  CAS  Google Scholar 

  58. Jozan S, Gay G, Marques B, Mirouze A, David JF (1985) Oestradiol is effective in stimulating 3H-thymidine incorporation, but not on proliferation of breast cancer cultured cells. Cell Tissue Kinet 18: 457–464

    PubMed  CAS  Google Scholar 

  59. Kaltenbach JP, Kaltenbach ΜΗ, Lyons WB (1958) Nigrosin as a dye for differentiating live and dead ascites cells. Exp Cell Res 15: 112–117

    PubMed  CAS  Google Scholar 

  60. Kennedy DG, Van den Berg HW, Clarke R, Murphy RF (1986) Enhancement of methotrexate cytotoxicity towards the MDA. MB. 436 human breast cancer cell line by dipyridamole. Biochem Pharmacol 35: 3053–3056

    PubMed  CAS  Google Scholar 

  61. Kern DH, Drogemuller CR, Kennedy MC, Hildebrand-Zanki SU, Tanigawa N, Sondak VK (1985) Development of a miniaturized, improved nucleic acid precursor incorporation assay for chemosensitivity testing of human solid tumors. Cancer Res 45: 5436–5441

    PubMed  CAS  Google Scholar 

  62. Klevjer-Anderson P, Buehring GC (1980) Effect of hormones on growth rates of malignant and nonmalignant human mammary epithelia in culture. In Vitro 16: 491– 501

    PubMed  CAS  Google Scholar 

  63. Kornblith PL, Smith BH, Leonard LA (1981) Response of cultured human brain tumours to nitrosoureas: correlation with clinical data. Cancer 47: 255–261

    PubMed  CAS  Google Scholar 

  64. Kwok TT, Twentyman PR (1985) The response to cytotoxic drugs of EMTG cells treated either as intact or disaggregated spheroids. Br J Cancer 51: 211–218

    PubMed  CAS  Google Scholar 

  65. Laboisse CL, Augeron C, Potet F (1981) Growth and differentiation of human gastrointestinal adenocarcinoma stem cells in soft agarose. Cancer Res 41: 310–315

    PubMed  CAS  Google Scholar 

  66. Lawler EM, Miller FR, Heppner GH (1983) Significance of three-dimensional growth patterns of mammary tissues in collagen gels. In Vitro 19: 600–610

    PubMed  CAS  Google Scholar 

  67. Leclercq G, Devleeschouwer N, Danguy A, Verrijdt A, Heuson JC (1985) In vitro synergism between estrogens and cytotoxic agents. J Steroid Biochem 23: 1111–1113

    PubMed  CAS  Google Scholar 

  68. Lee EYH, Lee WH, Kaetzel CS, Parry G, Bissell MJ (1985) Interaction of mouse mammary epithelial cells with collagenous substrata: regulation of casein gene expression and secretion. Proc Natl Acad Sci USA 82: 1419–1423

    PubMed  CAS  Google Scholar 

  69. Lickiss JN, Cane KA, Baikie AG (1974) In vitro drug selection in antineoplastic chemotherapy. Eur J Cancer 10: 809–814

    PubMed  CAS  Google Scholar 

  70. Limburg H, Heckmann C (1968) Chemotherapy in the treatment of advanced pelvic malignant disease with special reference to ovarian cancer. J Obstet Gynaecol 75:1246– 1250

    CAS  Google Scholar 

  71. Lippman ME, Cassidy J, Wesley M, Young RC (1985) Increasing the response rate to cytotoxic chemotherapy by endocrine means. J Steroid Biochem 23: 1173–1180

    PubMed  CAS  Google Scholar 

  72. Livingstone RB, Titus GA, Heilbrun LK (1980) In vitro effects on DNA synthesis as a predictor of biological effect from chemotherapy. Cancer Res 40: 2209–2212

    Google Scholar 

  73. Lykkesfelt AE, Larsen JK, Christensen IJ, Briand P (1984) Effects of the antioestrogen tamoxifen on the cell cycle kinetics of the human breast cancer cell line, MCF-7. Br J Cancer 49: 717–722

    Google Scholar 

  74. MacKintosh FR, Evans TL, Sikic BI (1981) Methodologic problems in clonogenic assays of spontaneous human tumours. Cancer Chemother Pharmacol 6: 205–210

    PubMed  CAS  Google Scholar 

  75. Madeddu L, Roy F, Leclercq G (1986) A new method for evaluating the inhibitory potency of antiestrogens on breast cancer cell lines. Anticancer Res 6: 11–16

    PubMed  CAS  Google Scholar 

  76. Mann BD, Kern DH, Guiliano AE, Burk MW, Campbell MA, Morton DL (1982) Clinical correlations with drug sensitivities in the clonogenic assay: retrospective pilot study. Arch Surg 117: 33–36

    PubMed  CAS  Google Scholar 

  77. Masters JRW (1983) An overview of the role of organ culture for human tumour biopsies. In: Dendy PP, Hill BT (ed) Human tumour drug sensitivity testing in vitro. Academic, London, pp 163–177

    Google Scholar 

  78. Matsushima Y, Kanzawa F, Hoshi A, Shimizu E, Nomori H, Sasaki Y, Saijo N (1985) Time-schedule dependency of the inhibiting activity of various anticancer drugs in the clonogenic assay. Cancer Chemother Pharmacol 14: 104–107

    PubMed  CAS  Google Scholar 

  79. Mattern J, Volm M (1982) Clinical relevance of predictive tests for cancer chemotherapy. Cancer Treat Rev 9: 267–298

    PubMed  CAS  Google Scholar 

  80. McGrath CM (1983) Augmentation of response of normal mammary epithelial cells to estradiol by mammary stroma. Cancer Res 43: 1355–1360

    PubMed  CAS  Google Scholar 

  81. Miller BE, McInerney D, Jackson D, Miller FR (1986) Metabolic cooperation between mouse mammary tumor subpopulations in three-dimensional collagen gel cultures. Cancer Res 46: 89–93

    PubMed  CAS  Google Scholar 

  82. Miller FR, Medina D, Heppner GH (1981) Preferential growth of mammary tumors in intact mammary fat pads. Cancer Res 41: 3863–3867

    PubMed  CAS  Google Scholar 

  83. Miller BE, Miller FR, Heppner GH (1984) Assessing tumor drug sensitivity by a new in vitro assay which preserves tumor heterogeneity and subpopulation interactions. J Cell Physiol [Suppl] 3: 105–116

    CAS  Google Scholar 

  84. Miller BE, Miller FR, Heppner GH (1985) Factors affecting growth and drug sensitivity of mouse mammary tumor lines in collagen gel cultures. Cancer Res 45: 4200–4205

    PubMed  CAS  Google Scholar 

  85. Moon TE (1980) Quantitative and statistical analysis of the association between in vitro and in vivo studies. In: Salmon SE (ed) Cloning of human tumor stem cells. Liss, New York, pp 209–221

    Google Scholar 

  86. Morgan D, Freshney RI, Darling JL, Thomas DGT, Celik F (1983) Assay of anticancer drugs in tissue culture: cell cultures of biopsies from human astrocytoma. Br J Cancer 47: 205–214

    PubMed  CAS  Google Scholar 

  87. Myers CE, Young RC, Chabner BA (1976) Kinetic alterations induced by 5-fluorouracil in bone marrow, intestinal mucosa, and tumor. Cancer Res 36: 1653–1658

    PubMed  CAS  Google Scholar 

  88. Nederman T, Twentyman P (1984) Spheroids for studies of drug effects. In: Acker H, Carlsson J, Durand R, Sutherland R (eds) Spheroids in cancer research. Springer, Berlin Heidelberg New York, pp 84–102 (Recent results cancer research, vol 95)

    Google Scholar 

  89. Osborne CK, Boldt DH, Estrada P (1984) Human breast cancer cell cycle synchronization by oestrogens and antioestrogens in culture. Cancer Res 44: 1433–1439

    PubMed  CAS  Google Scholar 

  90. Osborne CK, Von Hoff DD, Mullins K (1985) Endocrine therapy testing of human breast cancers in the soft agar clonogenic assay. Breast Cancer Res Treat 6: 229–235

    PubMed  CAS  Google Scholar 

  91. Ozols R, Gratzinger K, Myers C, Young RC (1979) Ovarian cancer (OC): intraperitoneal (IP) therapy with adriamycin (ADR). Proc Am Assoc Cancer Res 20: 978

    Google Scholar 

  92. Page MJ, Field JK, Everett NP, Green CD (1983) Serum regulation of the estrogen responsiveness of the human breast cancer cell line MCF-7. Cancer Res 43: 1244– 1250

    PubMed  CAS  Google Scholar 

  93. Park CH, Bergasgel DE, McCulloch EA (1971) Mouse myeloma tumor stem cells: a primary cell culture assay. J N C I 46: 411–422

    CAS  Google Scholar 

  94. Poulsen HS, Bichel P, Andersen J (1982) Short-term culture of human breast cancer: in vitro effects of hormones related to patient response. Br J Cancer 46: 67–74

    PubMed  CAS  Google Scholar 

  95. Puck TT, Marcus PI (1955) A rapid method of viable cell titration and clone production with Hela cells in tissue culture: the use of X-irradiated cells to supply conditioning factors. Proc Natl Acad Sci USA 41: 432–437

    PubMed  CAS  Google Scholar 

  96. Reddel RR, Murphy LC, Sutherland RL (1984) Factors affecting the sensitivity of T-47D human breast cancer cells to tamoxifen. Cancer Res 44: 2398–2405

    PubMed  CAS  Google Scholar 

  97. Richards J, Pasco D, Yang J, Guzman R, Nandi S (1983) Comparison of the growth of normal and neoplastic mouse mammary cells on plastic, on collagen gels and in collagen gels. Exp Cell Res 146: 1–14

    PubMed  CAS  Google Scholar 

  98. Roobol C, Sips HCM, Theunissen J, Atassi G, Bernheim JL (1984) In vitro assessment of cytotoxic agents in murine cancers: comparison between antiproliferative and antimetabolic assays. J N C I 72: 661–666

    CAS  Google Scholar 

  99. Rose C, Mouridsen HT (1984) Combined cytotoxic and endocrine therapy in breast cancer. In: Bresciani F, King RJB, Lippman ME, Namer M, Raynaud J-P (eds) Progress in cancer research and therapy vol 31. Raven, New York, pp 269–286

    Google Scholar 

  100. Rosenblum ML, Dougherty DV, Reese C, Wilson CB (1981) Potentials and possible pitfalls of human stem cell analysis. Cancer Chemother Pharmacol 6: 227–235

    PubMed  CAS  Google Scholar 

  101. Salmon SE, Alberts DS, Durie BGM, Meyskens FL, Jones SE, Soehnlen B, Chen WS, Moon T (1980) Clinical correlations of drug sensitivity in the human tumor stem cell assay. In: Mathe G, Muggia FM (eds) Cancer chemo- and immunopharmacology I. Springer, Berlin Heidelberg New York, pp. 300–305 (Recent results in cancer research, vol 74)

    Google Scholar 

  102. Salmon SE, Hamburger AW, Soehnlen B, Durie BG, Alberts DS, Moon TE (1978) Quantitation of differential sensitivity of human tumor stem cells to anticancer drugs. N Engl J Med 298: 1321–1327

    PubMed  CAS  Google Scholar 

  103. Salmon SE, Trent JM (eds) (1984) Human tumor cloning. Grune and Stratton, Orlando

    Google Scholar 

  104. Sandbach J, Von Hoff DD, Clark G, Cruz AB, O’ Brien M (1982) Direct cloning of human breast cancer in soft agar culture. Cancer 50: 1315–1321

    PubMed  CAS  Google Scholar 

  105. Sanfilippo O, Daidone MG, Costa A, Canetta R, Silvestrini R (1981) Estimation of differential in vitro sensitivity of non-Hodgkin lymphomas to anticancer drugs. Eur J Cancer 17: 217–226

    PubMed  CAS  Google Scholar 

  106. Sasaki T, Yamamoto M, Kuwahara K (1984) Lethal effect of bleomycin and peplo- mycin on Hela cells in multicell tumor spheroids. Cancer Res 44: 1374–1379

    PubMed  CAS  Google Scholar 

  107. Sato G (1975) The role of serum in culture. In: Litwak G (ed) Biochemical action of hormones, vol 3. Academic, New York, pp 391–396

    Google Scholar 

  108. Sauter C, Cogoli M, Arrenbrecht S (1986) Interactions of cytotoxic and other drugs: rapid cell culture assay. Oncology 43: 46–49

    PubMed  CAS  Google Scholar 

  109. Selby P, Buick RN, Tannock I (1983) A critical appraisal of the “Human tumour stemcell assay”. N. Engl J Med 308: 129–134

    CAS  Google Scholar 

  110. Sikic BI, Taber RL (1981) Human tumor clonogenic assays. Cancer Chemother Pharmacol 6: 201–203

    PubMed  CAS  Google Scholar 

  111. Silvestrini R, Daidone MG, Costa A, Sanfilippo O (1985) Cell kinetics and in vitro chemosensitivity as a tool for improved management of patients. Eur J Cancer Clin Oncol 21: 371–378

    PubMed  CAS  Google Scholar 

  112. Smith HS, Lan S, Ceriani R, Hackett AJ, Stampfer MR (1981) Clonal proliferation of cultured nonmalignant and malignant human breast epithelia. Cancer Res 41: 4637– 4643

    PubMed  CAS  Google Scholar 

  113. Smith HS, Lippman ME, Hiller AJ, Stampfer MR, Hackett AJ (1985) Response to doxorubicin of cultured normal and cancerous human mammary epithelial cells. J N C I 74: 341–347

    CAS  Google Scholar 

  114. Sondak VK, Bertelsen CA, Tanigawa N, Hildebrand-Zanki SU, Morton DL, Korn EL, Kern DH (1984) Clinical correlations with chemosensitivities measured in a rapid thymidine incorporation assay. Cancer Res 44: 1725–1728

    PubMed  CAS  Google Scholar 

  115. Sondak VK, Giuliano AE, Kern DH (1984) Outcome of “non-malignant” specimens submitted for soft-agar clonogenic assay. In: Salmon SE, Trent JM (eds) Human tumor cloning. Grune and Stratton, Orlando, pp 327–341

    Google Scholar 

  116. Soule HD, McGrath CM (1986) A simplified method for passage and long-term growth of human mammary epithelial cells. In Vitro Cell Dev Biol 22: 6–12

    PubMed  CAS  Google Scholar 

  117. Speyer JL, Collins JM, Dedrick RL, Brennan MF, Londer H, DeVita VT Jr, Myers CE (1979) Phase I and pharmacological studies of intraperitoneal (IP) 5-fluorouracil (5- FU). Proc Am Soc Clin Oncol 20: C-251

    Google Scholar 

  118. Sutherland RM, Durand RE (1976) Radiation response of multicell spheroids: an in vitro tumour model. Curr Top Radiat Res 11: 87–139

    CAS  Google Scholar 

  119. Tanigawa N, Kern DH, Hikasa Y, Morton DL (1982) Rapid assay for evaluating the chemosensitivity of human tumors in soft agar culture. Cancer Res 42: 2159–2164

    PubMed  CAS  Google Scholar 

  120. Taylor-Papadimitriou J, Sheares M, Stoker MGP (1977) Growth requirements of human mammary epithelial cells in culture. Int J Cancer 20: 903–908

    PubMed  CAS  Google Scholar 

  121. Thomas DGT, Darling JL, Paul EA, Mott TJ, Godlee JN, Tobias JS, Capra LG, Collins CD, Mooney C, Bozek T, Finn GP, Arigbabu SO, Bullard DE, Shannon N, Freshney RI (1985) Assay of anti-cancer drugs in tissue culture: relationship of relapse free interval (RFI) and in vitro chemosensitivity in patients with malignant cerebral glioma. Br J Cancer 51: 525–532

    PubMed  CAS  Google Scholar 

  122. Tubiana M, Pejovic MH, Chavaudra N, Contesso G, Malaise EP (1984) The long-term prognostic significance of the thymidine labelling index of breast cancer. Int J Cancer 33: 441–445

    PubMed  CAS  Google Scholar 

  123. Twentyman PR (1985) Predictive chemosensitivity testing. Br J Cancer 51: 295–299

    PubMed  CAS  Google Scholar 

  124. Twentyman PR, Fox NE, Wright KA, Workman P, Broadhurst MJ, Martin JA, Bleehen NM (1986) The in vitro effects and cross-resistance patterns of some novel anthracyclines. Br J Cancer 53: 585–594

    PubMed  CAS  Google Scholar 

  125. Twentyman PR, Walls GA, Wright KA (1984) The response of tumour cells to radiation and cytotoxic drugs—a comparison of clonogenic and isotope uptake assays. Br J Cancer 50: 625–631

    PubMed  CAS  Google Scholar 

  126. Van den Berg HW, Clarke R, Murphy RF (1981) Failure of 5-fluorouracil and methotrexate to destroy the reproductive integrity of a human breast cancer cell line (MCF-7) growing in vitro. Eur J Cancer Clin Oncol 17: 1275–1281

    PubMed  Google Scholar 

  127. Volm M, Wayss K, Kaufmann M, Mattern J (1979) Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy. Eur J Cancer 15: 983–993

    PubMed  CAS  Google Scholar 

  128. Von Hoff DD, Clark GM, Forseth BJ, Cowan JD (1986) Simultaneous in vitro drug sensitivity testing on tumours from different sites in the same patient. Cancer 58: 1007– 1013

    Google Scholar 

  129. Von Hoff DD, Clark GM, Weiss GR, Marshall MH, Buchok JB, Knight III WA, LeMaistre CF (1986) Use of in vitro dose response effects to select antineoplastics for high-dose or regional administration regimens. J Clin Oncol 4: 1827–1834

    Google Scholar 

  130. Von Hoff DD, Cowan J, Harris G, Reisdorf G (1981) Human tumor cloning: feasibility and clinical correlations. Cancer Chemother Pharmacol 6: 265–271

    Google Scholar 

  131. Von Hoff DD, Forseth B, Gonzales L (1986) Culture and sensitivity of tumors. Tex Med 82: 32–35

    Google Scholar 

  132. Von Hoff DD, Forseth B, Warfel LE (1985) Use of a radiometric system to screen for antineoplastic agents: correlation with a human tumor cloning system. Cancer Res 45: 4032–4038

    Google Scholar 

  133. Weichselbaum RR, Nove J, Heilman S, Piro AJ, Little JB (1979) Combination hormonal, chemotherapy and radiotherapy in vitro: implications for therapy in vivo. Int J Radiat Oncol Biol Phys 5: 1657–1661

    PubMed  CAS  Google Scholar 

  134. Weisenthal LM, Marsden JA, Dill PL, Macaluso CK (1983) A novel dye exclusion method for testing in vitro chemosensitivity of human tumors. Cancer Res 43: 749–757

    PubMed  CAS  Google Scholar 

  135. Wei-Zen W, Massey RJ, Heppner GH (1985) A 3-dimensional tumour growth inhibition assay for testing monoclonal antibody cytotoxicity. Cancer Immunol Immunother 20: 137–144

    Google Scholar 

  136. Wheeler TK, Dendy PP, Dawson A (1974) Assessment of an in vitro screening test of cytotoxic agents in the treatment of advanced malignant disease. Oncology 30: 362–376

    PubMed  CAS  Google Scholar 

  137. Wilde CJ, Hasan HR, Mayer RJ (1984) Comparison of collagen gels and mammary extracellular matrix as substrata for study of terminal differentiation in rabbit mammary epithelial cells. Exp Cell Res 151: 519–532

    PubMed  CAS  Google Scholar 

  138. Wilson AP, Ford CHJ, Newman CE, Howell A (1984) A comparison of three assays used for the in vitro chemosensitivity testing of human tumours. Br J Cancer 49: 57–63

    PubMed  CAS  Google Scholar 

  139. Wilson AP, Neal FE (1981) In vitro sensitivity of human ovarin tumours to chemotherapeutic agents. Br J Cancer 44: 189–200

    PubMed  CAS  Google Scholar 

  140. Wright JC, Cobb JP, Gumport SL, Golomb FM, Safodi D (1957) Investigation of the relation between clinical and tissue culture response to chemotherapeutic agents of human cancer. New Engl J Med 257: 1207–1211

    PubMed  CAS  Google Scholar 

  141. Yang J, Elias JJ, Petrakis NL, Wellings SR, Nandi S (1982) Effects of hormones and growth factors on human mammary epithelial cells in collagen gel culture. Cancer Res 41: 1021–1027

    Google Scholar 

  142. Yang J, Larson L, Flynn D, Elias J, Nandi S (1982) Serum-free primary culture of human normal mammary epithelial cells in collagen gel matrix. Cell Biol Int Rep 6:965– 975

    Google Scholar 

  143. Yang N, Kube D, Park C, Furmanski P (1981) Growth of human mammary epithelial cells on collagen gel surfaces. Cancer Res 41: 4093–4100

    PubMed  CAS  Google Scholar 

  144. Yuhas JM, Li AP, Martinez AO, Ladman AJ (1977) A simplified method for production and growth of multicellular tumour spheroids. Cancer Res 37: 3639–3643

    PubMed  CAS  Google Scholar 

  145. Zirvi KA, Hill GJ, Hill HZ (1986) Comparative studies of chemotherapy of human tumor cells in vitro by tritiated thymidine uptake inhibition and soft agar clonogenic assay. J Surg Oncol 31: 123–126

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anatomy, University of British Columbia, Vancouver, BC, Canada

    J. T. Emerman

Authors
  1. J. T. Emerman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medical Oncology, Cancer Control Agency of British Columbia, 600 West 10th Avenue, Vancouver, B.C., V5Z 4E6, Canada

    Joseph Ragaz MD, FRCP

  2. Foundation for Clinical Research Inc., 80 East End Avenue, New York, NY, 10028, USA

    Irving M. Ariel MD

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Emerman, J.T. (1989). In Vitro Predictive Sensitivity Testing in the Therapeutic Assessment of Breast Cancer. In: Ragaz, J., Ariel, I.M. (eds) High-Risk Breast Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73718-3_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73718-3_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-73720-6

  • Online ISBN: 978-3-642-73718-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation